Skip to Main Content

Author Details

Erica A Voss
Erasmus University Medical Center
2014
20
9
PMIDPaper TitleJournal TitlePublished Year
36826399Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational study.J Am Med Inform Assoc2023
37034358Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study.EClinicalMedicine2023
36826399Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational study.J Am Med Inform Assoc2023
37034358Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study.EClinicalMedicine2023
36227072Transforming and evaluating the UK Biobank to the OMOP Common Data Model for COVID-19 research and beyond.J Am Med Inform Assoc2022
35653017Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study.Drug Saf2022
35650169Baseline risk characterization of early versus later adopters of long-acting paliperidone palmitate formulations.Neuropsychopharmacol Rep2022
36227072Transforming and evaluating the UK Biobank to the OMOP Common Data Model for COVID-19 research and beyond.J Am Med Inform Assoc2022
35810265Hip Fracture Risk After Treatment with Tramadol or Codeine: An Observational Study.Drug Saf2022
36463160Social determinants of health associated with COVID-19 severity during pregnancy: a multinational cohort study (in the International Registry of Coronavirus Exposure in Pregnancy).BMC Public Health2022
35653017Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study.Drug Saf2022
35650169Baseline risk characterization of early versus later adopters of long-acting paliperidone palmitate formulations.Neuropsychopharmacol Rep2022
35810265Hip Fracture Risk After Treatment with Tramadol or Codeine: An Observational Study.Drug Saf2022
36463160Social determinants of health associated with COVID-19 severity during pregnancy: a multinational cohort study (in the International Registry of Coronavirus Exposure in Pregnancy).BMC Public Health2022
34180161Medications for attention-deficit/hyperactivity disorder in Japan: A retrospective cohort study of label compliance.Neuropsychopharmacol Rep2021
34180161Medications for attention-deficit/hyperactivity disorder in Japan: A retrospective cohort study of label compliance.Neuropsychopharmacol Rep2021
33731009Understanding patient journey in ulcerative colitis prior to biologic initiation: a 5-year exploration.BMC Gastroenterol2021
33731009Understanding patient journey in ulcerative colitis prior to biologic initiation: a 5-year exploration.BMC Gastroenterol2021
31910437Development and validation of a prognostic model predicting symptomatic hemorrhagic transformation in acute ischemic stroke at scale in the OHDSI network.PLoS One2020
31910437Development and validation of a prognostic model predicting symptomatic hemorrhagic transformation in acute ischemic stroke at scale in the OHDSI network.PLoS One2020
31456304Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases.Pharmacoepidemiol Drug Saf2019
31933226Liver Test Monitoring: Real-World Compliance for Drugs with Monitoring Requirements at 2-Week Intervals or More Frequently.Pharmaceut Med2019
31456304Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases.Pharmacoepidemiol Drug Saf2019
31933226Liver Test Monitoring: Real-World Compliance for Drugs with Monitoring Requirements at 2-Week Intervals or More Frequently.Pharmaceut Med2019
27993747Accuracy of an automated knowledge base for identifying drug adverse reactions.J Biomed Inform2017
28392100Risk Prediction for Ischemic Stroke and Transient Ischemic Attack in Patients Without Atrial Fibrillation: A Retrospective Cohort Study.J Stroke Cerebrovasc Dis2017
27993747Accuracy of an automated knowledge base for identifying drug adverse reactions.J Biomed Inform2017
28392100Risk Prediction for Ischemic Stroke and Transient Ischemic Attack in Patients Without Atrial Fibrillation: A Retrospective Cohort Study.J Stroke Cerebrovasc Dis2017
25730525Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database.Int Clin Psychopharmacol2015
25887092The impact of standardizing the definition of visits on the consistency of multi-database observational health research.BMC Med Res Methodol2015
25670757Feasibility and utility of applications of the common data model to multiple, disparate observational health databases.J Am Med Inform Assoc2015
25730525Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database.Int Clin Psychopharmacol2015
26014368Prevalence of Chronic Metoclopramide Use and Associated Diagnoses in the US Pediatric Population.Paediatr Drugs2015
25887092The impact of standardizing the definition of visits on the consistency of multi-database observational health research.BMC Med Res Methodol2015
26014368Prevalence of Chronic Metoclopramide Use and Associated Diagnoses in the US Pediatric Population.Paediatr Drugs2015
25670757Feasibility and utility of applications of the common data model to multiple, disparate observational health databases.J Am Med Inform Assoc2015
24526267Exposure to oral fluoroquinolones and the risk of retinal detachment: retrospective analyses of two large healthcare databases.Drug Saf2014
24985530Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest.Drug Saf2014
24526267Exposure to oral fluoroquinolones and the risk of retinal detachment: retrospective analyses of two large healthcare databases.Drug Saf2014
24985530Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest.Drug Saf2014
  • 1 - 40 of 40

Recommended Authors

University of Florida
Career Start Year 2017
Number of shared co-authors 8
Moderna Inc.
Career Start Year 2015
Number of shared co-authors 0
the Perelman School of Medicine, University of Pennsylvania
Career Start Year 2015
Number of shared co-authors 2
Columbia University
Career Start Year 2015
Number of shared co-authors 3
Johns Hopkins Bloomberg School of Public Health
Career Start Year 2012
Number of shared co-authors 1
Harvard Medical School and Harvard Pilgrim Health Care Institute
Career Start Year 2012
Number of shared co-authors 0
Harvard Medical School
Career Start Year 2011
Number of shared co-authors 5
Center for Quantitative Health, Massachusetts General Hospital
Career Start Year 2010
Number of shared co-authors 0
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2009
Number of shared co-authors 3
University of Pennsylvania Perelman School of Medicine
Career Start Year 2007
Number of shared co-authors 1
University of Toronto
Career Start Year 2007
Number of shared co-authors 0
Harvard Medical School
Career Start Year 2006
Number of shared co-authors 0
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2006
Number of shared co-authors 2
Harvard Medical School and Harvard Pilgrim Health Care Institute
Career Start Year 2006
Number of shared co-authors 5
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Career Start Year 2005
Number of shared co-authors 4
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 1
University of North Carolina at Chapel Hill
Career Start Year 2002
Number of shared co-authors 2
Rutgers University Institute for Health, the State University of New Jersey
Career Start Year 2001
Number of shared co-authors 3
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 4
University of Washington
Career Start Year 1997
Number of shared co-authors 1
Institute of General Practice and Family Medicine, University Hospital
Career Start Year 1996
Number of shared co-authors 1
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Career Start Year 1996
Number of shared co-authors 5
Harvard Medical School and Harvard Pilgrim Health Care Institute
Career Start Year 1995
Number of shared co-authors 6
College of Medicine, University of Florida
Career Start Year 1990
Number of shared co-authors 4
Columbia University.
Career Start Year 1990
Number of shared co-authors 21
Center for Drug Evaluation and Research
Career Start Year 1989
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 1988
Number of shared co-authors 3
Weill Cornell Medical College
Career Start Year 1987
Number of shared co-authors 2
Institute of Health Policy, University of Toronto
Career Start Year 1984
Number of shared co-authors 0

Collaborators

Columbia University Irving Medical Center
Co-authored papers 13
University of California los angeles
Co-authored papers 6
Janssen Pharmaceutical Research & Development
Co-authored papers 4
Erasmus University Medical Center
Co-authored papers 4
Janssen Pharmaceutical Research and Development LLC
Co-authored papers 4
Janssen Pharmaceutical Research and Development
Co-authored papers 4
OHDSI Center at The Roux Institute, Northeastern University
Co-authored papers 3
Institute of Health Informatics, University College London
Co-authored papers 3
Erasmus University Medical Center
Co-authored papers 3
University of California los angeles
Co-authored papers 3
University of Oxford
Co-authored papers 3
Janssen Pharmaceutical Research and Development
Co-authored papers 3
Janssen Pharmaceutical Research and Development
Co-authored papers 3
O'Brien Institute for Public Health, University of Calgary
Co-authored papers 3
Janssen Pharmaceutical Research & Development
Co-authored papers 3
Stanford University
Co-authored papers 2
University of Pittsburgh
Co-authored papers 2
University of Dundee
Co-authored papers 2
Columbia University
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Riyadh Elm University
Co-authored papers 2
Erasmus University Medical Center
Co-authored papers 2
Hospital del Mar Medical Research Institute
Co-authored papers 2
Hospital del Mar
Co-authored papers 1
University of New Mexico
Co-authored papers 1
Zhongshan School of Medicine, Sun Yat-Sen University
Co-authored papers 1
University of Gothenburg
Co-authored papers 1
College of Ethnic Medicine, Yunnan University of Chinese Medicine
Co-authored papers 1
Quality Use of Medicines and Pharmacy Research Centre, University of South Australia
Co-authored papers 1
Columbia University Irving Medical Center
Co-authored papers 1